296
Views
60
CrossRef citations to date
0
Altmetric
Article

Will Medical Solutions to Sexual Problems Make Sexological Care and Science Obsolete?

Pages 385-397 | Published online: 02 Aug 2007
 

Abstract

Developments in the field of sexology indicate a trend toward the medicalization of sexual issues which is likely to continue over the next decades. With the introduction of new pharmacological treatments, the resulting shift from the biopsychosocial model to the disease model will become increasingly accepted and solidified over the next decade. Some of this shift may be beneficial in that the healthcare needs of the patient/client may at times be better served through this route. However, concern arises when such shifts are likely to limit the meaningful choices presented to the patient and to dampen support for basic psycho-behavioral and neurophysiological sexological investigation. Such developments challenge sexologists and sex therapists to define their treatment outcomes more clearly and, relying on stronger evidence-based studies, define the critical role of the therapist in achieving these outcomes.

This article is an English language rendition of an article published in Dutch in the journal Tijdschrift voor Seksuologie. Permission to reprint the article in English has been granted.

Notes

1Defined as the inability to respond adequately sexually and thereby preventing successful and/or fulfilling sexual relations with a partner.

2The concept was first introduced to issues of health and illness by George Engel in 1977.

3Success is defined here by the reinstatement of erectile response rather than a return to overall sexual and treatment satisfaction, which were known to be quite low with the use of this treatment.

4The Medline database provided the reference source.

5It is generally recognized that the introduction of anti-psychotic drugs to successfully treat schizophrenia dampened basic research on the condition.

6Experts in clinical psychology have successfully used other types of research models as investigatory tools; they have also pointed out how and why data from double blind placebo-controlled studies may sometimes not provide reliable or valid data on an issue (American Psychological Association, 2007a and b)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.